AstraZeneca PLC annual revenue for fiscal TTM was $60.4 billion, an increase of 2.9% from $58.7 billion in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
| Revenue (annual) | TTM → 2026-03-31 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $60.4B | $58.7B | $54.1B | $45.8B | $44.4B | $37.4B | $26.6B | $24.4B | $22.1B | $22.5B | $23.0B | $24.7B | $26.5B | $25.8B | $28.0B | $33.6B | $33.3B | $32.8B | $31.6B | $29.6B | $26.5B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Revenue (quarterly) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $15.3B | $15.5B | $15.2B | $14.5B | $13.6B | $14.9B | $13.6B | $12.9B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
More AZN metrics: Gross Profit · Operating Income · Net Income · EPS · EBITDA · Free Cash Flow · Shares Outstanding
All AZN financial statements → Interactive AZN charts →
About TickerBase · Data methodology & sources